Comparison of patency and cost-effectiveness of self-expandable metal and plastic stents used for malignant biliary strictures: a Polish single-center study

Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1223-8. doi: 10.1097/MEG.0000000000000699.

Abstract

Introduction: Most patients with malignant biliary obstruction are suited only for palliation by endoscopic drainage with plastic stents (PS) or self-expandable metal stents (SEMS).

Objective: To compare the clinical outcome and costs of biliary stenting with SEMS and PS in patients with malignant biliary strictures.

Patients and methods: A total of 114 patients with malignant jaundice who underwent 376 endoscopic retrograde biliary drainage (ERBD) were studied.

Results: ERBD with the placement of PS was performed in 80 patients, with one-step SEMS in 20 patients and two-step SEMS in 14 patients. Significantly fewer ERBD interventions were performed in patients with one-step SEMS than PS or the two-step SEMS technique (2.0±1.12 vs. 3.1±1.7 or 5.7±2.1, respectively, P<0.0001). The median hospitalization duration per procedure was similar for the three groups of patients. The patients' survival time was the longest in the two-step SEMS group in comparison with the one-step SEMS and PS groups (596±270 vs. 276±141 or 208±219 days, P<0.001). Overall median time to recurrent biliary obstruction was 89.3±159 days for PS and 120.6±101 days for SEMS (P=0.01). The total cost of hospitalization with ERBD was higher for two-step SEMS than for one-step SEMS or PS (1448±312, 1152±135 and 977±156&OV0556;, P<0.0001). However, the estimated annual cost of medical care for one-step SEMS was higher than that for the two-step SEMS or PS groups (4618, 4079, and 3995&OV0556;, respectively).

Conclusion: Biliary decompression by SEMS is associated with longer patency and reduced number of auxiliary procedures; however, repeated PS insertions still remain the most cost-effective strategy.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cholangiopancreatography, Endoscopic Retrograde / adverse effects
  • Cholangiopancreatography, Endoscopic Retrograde / economics*
  • Cholangiopancreatography, Endoscopic Retrograde / instrumentation*
  • Cholangiopancreatography, Endoscopic Retrograde / mortality
  • Cholestasis / diagnostic imaging
  • Cholestasis / economics*
  • Cholestasis / mortality
  • Cholestasis / therapy*
  • Constriction, Pathologic
  • Cost Savings
  • Cost-Benefit Analysis
  • Decompression, Surgical / adverse effects
  • Decompression, Surgical / economics*
  • Decompression, Surgical / instrumentation*
  • Decompression, Surgical / mortality
  • Drainage / adverse effects
  • Drainage / economics*
  • Drainage / instrumentation*
  • Drainage / mortality
  • Female
  • Hospital Costs*
  • Humans
  • Length of Stay / economics
  • Male
  • Metals / economics*
  • Middle Aged
  • Plastics / economics*
  • Poland
  • Prosthesis Design
  • Recurrence
  • Retrospective Studies
  • Stents / economics*
  • Time Factors
  • Treatment Outcome

Substances

  • Metals
  • Plastics